World Heart Day: experts demand urgent action on heart failure

News & Events

25 May 2016
AUTHOR: HFPN Admin

Representatives of the Heart Failure Policy Network secretariat were invited to join a panel of experts in cardiovascular disease as part of the World Heart Federation event for the 69th World Health Assembly in Geneva, Switzerland.

At the event, ‘Tackling CVD through Primary Health Care’, distinguished speakers included:

Chair and panellists discussed the significant gaps in patient access to health care services for cardiovascular disease at the primary health care level across the world, practical solutions that had been mounted to date, and outstanding challenges facing policy makers and health system leaders.

Speaking on behalf of the Members of the Heart Failure Policy Network, Ed Harding raised specific talking points on the need to provide accreditation for non-physician health workers and heart-specialist nurses as an example of much needed innovation and strategic preparedness in cardiovascular disease – which joined with many other calls to reinvent primary health care to meet pressing sustainability challenges.

Photos and discussion points were shared by on social media. To find out more, follow @worldheartfed and @hfpolicynetwork,  or the Heart Failure Policy Network’s campaign hashtag #changeHFpolicy.

Tagged:

More from News & Events

New French translation of The handbook of multidisciplinary
New French translation of The handbook of multidisciplinary ...
07 June 2021
The Heart Failure Policy Network has launched a French translation of The handbook of multidisciplinary and integrated heart failure care....
Read article
Webinar recording: ‘Freedom from heart failure: reimag
Webinar recording: ‘Freedom from heart failure: reimag...
14 May 2021
Watch the full webinar 'Freedom from heart failure: reimagining cardiac services in England' which was co-hosted by the Heart Failure Policy Network (HFPN) and the British Society ...
Read article
The Heart Failure Policy Network is made possible with financial support from AstraZeneca, Vifor Pharma and Novartis Pharma. The content produced by the Network is non-promotional and not biased to any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members.